Skip to main content

Pharmacology Articles

 

Clinical courses

 

Clinical research courses

  • NOOTROPICS- THE MEMORY INHANCEMENT DRUGS- A REVIEW

    About Author:
    Rahul Singh
    M.PHARMA (Pharmaceutics)
    Shri Rawatpura Sarkar Institute Of Pharmacy
    Kumhari, Distt-Durg , Chhatisgarh, India
    rahulbaba92@yahoo.in

  • A REVIEW ON DESCRIPTION AND COMPLETE TREATMENT OF TUBERCULOSIS (ALL TYPES)

    About Author:
    Rahul Singh
    M.PHARMA (Pharmaceutics)
    Shri Rawatpura Sarkar Institute Of Pharmacy
    Kumhari, Distt-Durg, Chhatishgarh, India
    rahulbaba92@yahoo.in

  • APPROACH OF PRODRUG ON DRUG DESIGN

    About Authors:
    Mayure Vijay kumar*, V. Sravanthi Yadav, C.P.Meher
    Department of Pharmacology,
    Maheshwara College of Pharmacy, Chitkul (v), Isnapur “X” Road,
    Patancheru, Hyderabad-502307

    *mayurevijaykumar@gmail.com

  • THE ROLE OF COX-2 INHIBITORS IN HUMAN CANCER PREVENTION AND OTHER NOVEL TARGETS - A RECENT REVIEW

    About Authors:
    Lohithasu Duppala*1, Madhu priya Damuluri1, Anil kumar vadda2
    1
    GITAM Institute of Pharmacy, GITAM University, Pharmaceutics, visakhapatnam, Andhra Pradesh, India-530045.
    2
    AVANTHI Institute of pharmaceutical sciences, pharmacology, visakhapatnam, Andhra Pradesh, India-530045.
    *
    lohithasu@gmail.com, anilkumar.vadda@gmail.com

    ABSTRACT:
    COX-2 (Cyclooxygenase-2) is a selective inhibitor of non-steroidal anti-inflammatory drug (NSAID). Cyclooxygenase -2, an enzyme responsible for inflammation and pain. Celecoxib, Rofecoxib, valdecoxib, Parecoxib are class of COX-2 inhibiting drugs. COX-2  inhibitors have been revealed to reduce the occurrence of cancers and pre-cancerous growths. Celecoxib, cox-2 inhibitor isused to prevention of polyp formation in Familial Adenomatous Polyposis (FAP). COX-2 inhibitors like celecoxib, Rofecoxib, valdecoxib, Parecoxibare currently being studied in  cancer treatment and other targets. This review highlights the COX-2 inhibitors with special emphasis on their role in various kinds of cancer prevention and other targeted therapy. COX-2 inhibitors in cancer chemotherapy and neurological diseases like Parkinson and Alzheimer’s diseases still continues to attract researches on the development of COX-2 inhibitors.

  • PHARMACOLOGICAL EVALUATION OF ETHANOLIC EXTRACT OF EMBELIA RIBES: (VIDANGA) FRUIT IN EXPERIMENTAL ANIMAL MODELS

    About Authors:
    Saritha.A.Surendran*, Asa Samuel
    *St. James College of Pharmaceutical Sciences,
    Chalakudy, Kerala
    *sarithaasurendran@gmail.com

    ABSTRACT
    Analgesics are the drug that selectively relieves pain by acting in the CNS or peripheral pain mechanism without significantly altering consciousness. They are classified into centrally acting analgesics and peripherally acting analgesics. Embelia ribes seeds was collected and extracted by continous hot percolation process using ethanol. Phytochemical analysis of the extract was preformed, screened and compared the analgesic activity of the extract with Pentazocine. Animal treated with ethanolic extract of Embelia ribes was showed an increased reaction time compared to control group. Ethanolic extract was showed significant reduction in algesia when compared with pentazocin.

  • TREATMENT OF MALARIA IN PAEDITRICS: A REVIEW

    About Author:
    Kambham Venkateswarlu
    Final Year Graduate Student
    Sri Lakshmi Narasimha College of Pharmacy,
    Palluru, Chottoor-517132, Andhra Pradesh, India.
    k.v.reddy9441701016@gmail.com

    ABSTRACT:
    Malaria is an infectious disease caused by a parasite (plasmodium) which is transmitted from human by the bite of infected female Anopheles mosquitoes. Four species of the parasite plasmodium are responsible for Malaria in humans: Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, Plasmodium falciparum.
    This disease cause a nearly 300 to 400 million clinical episodes of malaria occur worldwide, out of which 1.5 to 2 million die every year. So this is also a most dangerous disease in children. This review reveals the treatment of malaria in paediatrics.

  • A CLINICAL STUDY ON THERAPEUTIC MANAGEMENT OF VIRAL HEPATITIS-A IN PAEDITRICS

    About Author:
    Kambham Venkateswarlu
    1-Final Year Graduate Student
    Sri Lakshmi Narasimha College of Pharmacy,
    Palluru, Chottoor-517132, Andhra Pradesh, India.
    k.v.reddy9441701016@gmail.com

    ABSTRACT:
    Hepatitis is a general term meaning inflammation of the liver and can be caused by a variety of different viruses such as hepatitis-A, B, C, D, and E. Since the development of jaundice is a characteristic of liver disease, a correct diagnosis can only be made by testing patient’s sera for the presence of specific anti-viral antibiotics. Transmission of HAV is typically by the faecal, oral route. Hepatitis A was formerly called infectious hepatitis, Epidemic hepatitis, Epidemic jaundice, Catarrhal jaundice, type A hepatitis, HA.

  • Biosensor for HIV Diagnosis at All Stages of Infection- A Nano Idea

    About Authors:
    Dhanya V C
    Kasturba medical college, Manipal University
    Indian Veterinary Research Institute
    dhanya285@gmail.com

    INTRODUCTION:
    A biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical signals (1). Or in other words, Sensor that integrates a biological element with a physiochemical transducer to produce an electronic signal proportional to a single analyte which is then conveyed to a detector.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • REVIEW ON PROSTATE CANCER THERAPY

    About Authors:
    Kambham Venkateswarlu1*, G.Sujatha2
    1Graduate Student
    2Department of Pharmaceutical Chemistry
    Sri Lakshmi Narasimha College of Pharmacy, Palluru,
    Chittoor District, Andhra Pradesh-517132, India.
    *k.v.reddy9441701016@gmail.com

    I. INTRODUCTION
    1.1. WHAT IS PROSTATE CANCER?
    Prostate cancer is the most common type of cancer in men and is the second leading cause of cancer-related deaths in men worldwide. It is a disease of the prostate gland in which malignant cells form in the tissues of the prostate and multiply out of control. These cells often metastasize to other parts of the body, like the rectum, the bladder and especially, the bones and the lymph nodes. It generally arises near the surface of the gland so that it can be diagnosed easily by digital rectal examination (DRE). Depending on the extent of metastasis, the prostate cancer tissue has been graded using the Gleason System into a score of 2 to 10 or into four stages I-IV (or, A-D), indicating the likelihood of spreading of the disease to other parts of the body.


    Although several types of cells are found in the prostate, over 99% of the cancers occur in the gland cells only (cells which make the prostate fluid which is added to the semen). Such type of cancer is termed as adenocarcinoma. The region of prostate gland where the adenocarcinoma is most common is the peripheral zone.  Other types of cancer can also start in the prostate gland, including sarcomas (like leiomyosarcoma and rhabdomyosarcoma), small cell carcinomas, and transitional cell carcinomas, although they are extremely rare. Generally, the cancer grows and spreads very slowly. Early prostate cancer most often causes no symptoms. Sometimes, however there are signs and symptoms very close to those of benign prostatic hyperplasia (BPH).

  • BRUGADA SYNDROME: DIAGNOSIS, ORIGIN, RELATION WITH OTHER SYNDROMES

    About Author:
    Kambham venkateswarlu
    Graduate student
    Sri Lakshmi Narasimha College of Pharmacy, Palluru,
    Chittoor District, Andhra Pradesh-517132, India.
    k.v.reddy9441701016@gmail.com

    ABSTRACT:
    Brugada syndrome is a genetic cause of sudden cardiac arrest characterized by abnormal electrocardiographic (ECG) pattern in the right precordial leads either at rest or after provocation. In this condition, sudden death may occur due to polymorphic ventricular tachycardia or ventricular fibrillation. In approximately 30% of patients, sudden cardiac arrest is the initial clinical manifestation of Brugada syndrome.

Subscribe to Pharmacology Articles